Continuous renal replacement therapy with vitamin E‐coated polysulfone hemofilter reduces inflammatory responses in a porcine lipopolysaccharide‐treated model
Therapeutic Apheresis and Dialysis · 2025
DOI: 10.1111/1744-9987.14183 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, 2025. Verfasst von Takumi Horikawa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical Technology and Material Laboratory, Research and Business Development Division, Asahi Kasei Medical Co., LTD., Shizuoka, Japan. Hauptthemen laut MEDLINE: Sulfones, Polymers, Lipopolysaccharides, Disease Models, Animal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Biological invasions may promote the onset of systemic inflammatory response syndrome in patients eligible for continuous renal replacement therapy (CRRT), leading to poor prognosis. Hence, we aimed to examine the inflammatory reactions in circulation using vitamin E‐coated polysulfone hollow fiber membrane (ViLIFE).
Methods
Lipopolysaccharides were intravenously administered to pigs (2 μg/kg/30 min) to establish an acute inflammation model. Extracorporeal circulation was performed for 6 h in continuous venovenous hemodiafiltration mode using a hemofilter for CRRT filled with a polysulfone hollow fiber membrane or ViLIFE, and the differences in inflammatory reactions were evaluated.
Results
The ViLIFE group exhibited low platelet and cytokine levels ( p < 0.05 vs. sham‐CRRT group). Additionally, the ViLIFE group had lower lactate and high mobility group box 1 levels than the other groups.
Conclusion
ViLIFE represents a promising CRRT modality that can inhibit the inflammatory response in circulation and inhibit further biological invasions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Technology and Material Laboratory, Research and Business Development Division, Asahi Kasei Medical Co., LTD., Shizuoka, Japan.
ORCID-Profile: Takumi Horikawa, Kana Yagi
Zitieren
APA
Horikawa, T., Yagi, K., Ishikawa, C., Atarashi, M., Watanabe, A., & Kato, Y. (2025). Continuous renal replacement therapy with vitamin E‐coated polysulfone hemofilter reduces inflammatory responses in a porcine lipopolysaccharide‐treated model. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.14183
Vancouver
Horikawa T, Yagi K, Ishikawa C, Atarashi M, Watanabe A, Kato Y. Continuous renal replacement therapy with vitamin E‐coated polysulfone hemofilter reduces inflammatory responses in a porcine lipopolysaccharide‐treated model. Therapeutic Apheresis and Dialysis. 2025. doi:10.1111/1744-9987.14183
BibTeX
@article{Horikawa2025,
author = {Horikawa, Takumi and Yagi, Kana and Ishikawa, Chika and Atarashi, Machi and Watanabe, Atsushi and Kato, Yoshihisa},
title = {Continuous renal replacement therapy with vitamin E‐coated polysulfone hemofilter reduces inflammatory responses in a porcine lipopolysaccharide‐treated model},
journal = {Therapeutic Apheresis and Dialysis},
year = {2025},
doi = {10.1111/1744-9987.14183}
}
EUVIMED